Andon Health Co., Ltd.
SZSE:002432.SZ
34.97 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,592.196 | 3,231.125 | 26,315.361 | 2,397.098 | 2,008.36 | 706.276 | 563.88 | 597.919 | 420.138 | 397.858 | 425.452 | 407.567 | 356.082 | 354.132 | 298.702 | 313.158 | 279.505 | 216.942 |
| Cost of Revenue
| 760.198 | 1,275.023 | 5,367.195 | 875.549 | 877.505 | 502.937 | 394.942 | 414.893 | 284.355 | 295.563 | 292.619 | 274.701 | 237.331 | 235.935 | 196.93 | 207.698 | 194.961 | 139.022 |
| Gross Profit
| 1,831.998 | 1,956.102 | 20,948.166 | 1,521.548 | 1,130.855 | 203.34 | 168.938 | 183.026 | 135.783 | 102.295 | 132.833 | 132.866 | 118.751 | 118.196 | 101.771 | 105.46 | 84.544 | 77.921 |
| Gross Profit Ratio
| 0.707 | 0.605 | 0.796 | 0.635 | 0.563 | 0.288 | 0.3 | 0.306 | 0.323 | 0.257 | 0.312 | 0.326 | 0.333 | 0.334 | 0.341 | 0.337 | 0.302 | 0.359 |
| Reseach & Development Expenses
| 249.502 | 299.526 | 264.889 | 66.731 | 76.545 | 80.034 | 68.864 | 94.064 | 41.466 | 43.651 | 9.145 | 8.494 | 8.117 | 9.657 | 8.288 | 0 | 0 | 0 |
| General & Administrative Expenses
| 138.945 | 207.629 | 520.415 | 98.485 | 66.148 | 68.275 | 54.943 | 60.968 | 50.341 | 32.257 | 27.887 | 14.553 | 7.768 | 7.399 | 13.541 | 41.911 | 32.046 | 20.247 |
| Selling & Marketing Expenses
| 403.579 | 382.505 | 1,055.742 | 243.466 | 369.907 | 108.458 | 62.051 | 70.578 | 80.332 | 64.137 | 92.946 | 73.319 | 57.202 | 48.467 | 33.738 | 17.503 | 16.858 | 13.797 |
| SG&A
| 542.524 | 883.378 | 1,576.158 | 341.951 | 436.055 | 176.733 | 116.994 | 131.546 | 130.673 | 96.394 | 120.833 | 87.872 | 64.97 | 55.866 | 47.279 | 59.414 | 48.904 | 34.044 |
| Other Expenses
| -1,081.016 | -840.293 | 430.911 | 151.098 | 147.333 | 96.042 | 86.992 | 6.882 | 4.416 | 0.126 | 2.792 | 2.755 | 0.65 | 0.394 | 3.986 | 1.009 | -0.367 | 0.395 |
| Operating Expenses
| -277.804 | 342.611 | 2,271.957 | 559.78 | 659.932 | 352.809 | 282.848 | 349.622 | 268.663 | 232.239 | 215.825 | 148.489 | 126.507 | 108.326 | 83.106 | 59.414 | 48.904 | 34.044 |
| Operating Income
| 2,109.802 | 1,613.491 | 18,311.869 | 1,002.549 | 777.797 | -149.47 | -91.922 | -171.321 | 8.216 | -153.196 | 20.313 | -10.732 | 6.074 | 23.981 | 23.398 | 44.217 | 35.933 | 47.112 |
| Operating Income Ratio
| 0.814 | 0.499 | 0.696 | 0.418 | 0.387 | -0.212 | -0.163 | -0.287 | 0.02 | -0.385 | 0.048 | -0.026 | 0.017 | 0.068 | 0.078 | 0.141 | 0.129 | 0.217 |
| Total Other Income Expenses Net
| -2.932 | -33.146 | -54.012 | -2.917 | 1.165 | -2.155 | 86.992 | 13.811 | 4.407 | 0.127 | -10.387 | 2.752 | 16.525 | 15.668 | 3.986 | 1.009 | -0.367 | 4.445 |
| Income Before Tax
| 2,106.87 | 1,580.344 | 18,257.857 | 999.632 | 239.753 | 18.382 | -4.93 | -157.51 | 12.622 | -153.07 | 9.927 | -7.979 | 6.745 | 24.375 | 27.384 | 45.226 | 35.565 | 47.507 |
| Income Before Tax Ratio
| 0.813 | 0.489 | 0.694 | 0.417 | 0.119 | 0.026 | -0.009 | -0.263 | 0.03 | -0.385 | 0.023 | -0.02 | 0.019 | 0.069 | 0.092 | 0.144 | 0.127 | 0.219 |
| Income Tax Expense
| 306.828 | 231.112 | 1,773.763 | 65.229 | 2.925 | -8.678 | -2.071 | 8.361 | -1.876 | -2.309 | 1.534 | 1.383 | -0.208 | 3.568 | 3.668 | 6.185 | 4.261 | 3.602 |
| Net Income
| 1,668.727 | 1,251.608 | 16,030.169 | 908.642 | 242.329 | 27.06 | 12.687 | -165.861 | 14.498 | -150.761 | 10.198 | -9.168 | 6.983 | 20.807 | 23.716 | 39.041 | 31.304 | 43.905 |
| Net Income Ratio
| 0.644 | 0.387 | 0.609 | 0.379 | 0.121 | 0.038 | 0.022 | -0.277 | 0.035 | -0.379 | 0.024 | -0.022 | 0.02 | 0.059 | 0.079 | 0.125 | 0.112 | 0.202 |
| EPS
| 3.81 | 2.8 | 35.14 | 2 | 0.56 | 0.063 | 0.03 | -0.38 | 0.04 | -0.41 | 0.03 | -0.02 | 0.02 | 0.053 | 0.073 | 0.14 | 0.11 | 0.15 |
| EPS Diluted
| 3.78 | 2.77 | 34.3 | 2 | 0.56 | 0.063 | 0.03 | -0.38 | 0.04 | -0.41 | 0.03 | -0.02 | 0.02 | 0.053 | 0.073 | 0.14 | 0.11 | 0.15 |
| EBITDA
| 2,239.602 | 1,704.874 | 18,408.858 | 1,115.145 | 342.281 | 100.691 | 58.609 | -88.719 | 65.011 | -126.572 | 34.811 | 4.582 | 14.246 | 30.056 | 32.062 | 48.623 | 36.777 | 44.741 |
| EBITDA Ratio
| 0.864 | 0.528 | 0.7 | 0.465 | 0.17 | 0.143 | 0.104 | -0.148 | 0.155 | -0.318 | 0.082 | 0.011 | 0.04 | 0.085 | 0.107 | 0.155 | 0.132 | 0.206 |